DEEP TRACK CAPITAL LP
Q4 2021 Form 13-F
GREENWICH, CONNECTICUT
CIK 0001856083
· CRD 312459
· SEC-registered investment adviser
$1.4B Reported Value Total
DEEP TRACK CAPITAL, LP reports 3 total accounts under management (AUM). There are 3 discretionary accounts valued at $1,792,544,185, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
2 funds
· $8.4B gross asset value
Hedge Fund: $8.4B
Source: Form ADV filed 2026-03-31
Reported value
$1.4B
Quarter over quarter
0.0%
Holdings
49
Top-10 concentration
42.7%
Key People
Form ADV owners & control persons
David Eric Kroin
MANAGING MEMBER
Nir Salman Messafi
CHIEF OPERATING AND FINANCIAL OFFICER / CHIEF COMPLIANCE OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q4 2021 13F record
Q4 2021 13F filing summary
| Period of report | December 31, 2021 |
|---|---|
| Filed | February 14, 2022 |
| Form | 13F-HR |
| Reported value | $1.4B |
| Positions | 49 |
| Change in reported value | First reported quarter |
| Top-10 concentration | 42.7% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 16, 2026
|
71 | $6.1B |
|
Q2 2026 13F
Filed Aug 14, 2026
|
66 | $6.9B |
|
Q1 2026 13F
Filed May 15, 2026
|
62 | $6.1B |
|
Q4 2025 13F
Filed Feb 13, 2026
|
53 | $5.6B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
56 | $3.6B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
65 | $3.1B |
|
Q1 2025 13F
Filed May 15, 2025
|
69 | $3.1B |
|
Q4 2024 13F
Filed Feb 14, 2025
|
61 | $2.7B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
69 | $3.2B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
67 | $3.4B |
|
Q1 2024 13F
Filed May 15, 2024
|
65 | $3.5B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
57 | $3.0B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
62 | $2.6B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
53 | $2.2B |
|
Q1 2023 13F
Filed May 15, 2023
|
54 | $2.4B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
57 | $2.4B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
60 | $2.2B |
|
Q2 2022 13F
Filed Aug 12, 2022
|
49 | $1.5B |
|
Q1 2022 13F
Filed May 16, 2022
|
49 | $1.6B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
49 | $1.4B |
Top 20 holdings · Q4 2021
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | KROS KEROS THERAPEUTICS INC | $76.1M | 5.37% |
| 2 | TVTX TRAVERE THERAPEUTICS INC | $76.0M | 5.37% |
| 3 | BCYC BICYCLE THERAPEUTICS PLC | $67.0M | 4.73% |
| 4 | ISEE IVERIC BIO INC | $66.9M | 4.72% |
| 5 | JAZZ JAZZ PHARMACEUTICALS PLC | $63.7M | 4.5% |
| 6 | GBT GLOBAL BLOOD THERAPEUTICS IN | $58.5M | 4.13% |
| 7 | BEAM BEAM THERAPEUTICS INC | $55.8M | 3.94% |
| 8 | CRNX CRINETICS PHARMACEUTICALS IN | $54.0M | 3.81% |
| 9 | RPTX REPARE THERAPEUTICS INC | $44.3M | 3.13% |
| 10 | MDGL MADRIGAL PHARMACEUTICALS INC | $42.4M | 2.99% |
| 11 | FDMT 4D MOLECULAR THERAPEUTICS IN | $41.7M | 2.94% |
| 12 | NVCR NOVOCURE LTD | $41.3M | 2.92% |
| 13 | IMVT IMMUNOVANT INC | $40.7M | 2.87% |
| 14 | KDNY CHINOOK THERAPEUTICS INC | $39.5M | 2.79% |
| 15 | KURA KURA ONCOLOGY INC | $35.7M | 2.52% |
| 16 | DICE DICE THERAPEUTICS INC | $33.9M | 2.4% |
| 17 | JNCE JOUNCE THERAPEUTICS INC | $33.4M | 2.36% |
| 18 | ESPR ESPERION THERAPEUTICS INC NE | $28.2M | 1.99% |
| 19 | DYN DYNE THERAPEUTICS INC | $27.3M | 1.92% |
| 20 | VRDN VIRIDIAN THERAPEUTICS INC | $26.4M | 1.87% |
Values as reported on the Q4 2021 Form 13F. Every position is in the holdings table below.